A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson’s disease during chronic dopaminergic therapy

Journal of Neurology

Volumn 263, Issue 3, 2016, Pages 441-447

  Marchesi, Elena ^a   Negrotti, Anna ^a   Angelini, Monica ^a   Goldoni, Matteo ^b   Abrignani, Giorgia ^a   Calzetti, Stefano ^a,b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

DAergic drugs; Incidence; Parkinson s disease; Prevalence; RLS

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY ASSESSMENT; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RESTLESS LEGS SYNDROME; SENSORY DYSFUNCTION; CHEMICALLY INDUCED; INCIDENCE; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

AGED; DOPAMINE AGENTS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARKINSON DISEASE; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX;

EID: 84960379148     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7937-7     Document Type: Article

References (17)

1. Rijsman RM, Schoolderman LF, Rundervoort RS, Louter M (2014) Restless legs syndrome in Parkinson’s disease. Parkinsonism Relat Disord 20S1: S5–S9
2. Calzetti S, Angelini M, Negrotti A, Marchesi E, Goldoni M (2014) A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson’s disease. J Neural Transm 121:499–506
3. Angelini M, Negrotti A, Marchesi E, Bonavina G, Calzetti S (2011) A study of prevalence of restless legs syndrome in previously untreated Parkinson’s disease patients: absence of co-morbid association. J Neurol Sci 310:286–288
4. Gjerstad MD, Tysnes OB, Larsen JP (2011) Increased risk of leg motor restlessness but not RLS in early Parkinson’s disease. Neurology 77:1941–1946
5. Wong JC, Li Y, Schwarzschild MA, Ascherio A, Gao X (2014) Restless Legs Syndrome: an early feature of Parkinson’s Disease in Men. Sleep 37(2):369–372
6. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J (2003) Restless legs syndrome: diagnostic criteria, special considerations and epidemiology; A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–109
7. Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, on the behalf of the IRLSSG (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria—history, rationale, description and significance. Sleep Med 15:860–873
8. The International Restless Legs Syndrome Study Group (2003) Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4:121–132
9. Allen RP, Ondo WG, Ball E, Calloway MO, Manjunath R, Higbie RL, Lee MR, Nisbet PA (2011) Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep Med 12:431–439
10. Tomlison C, Stowe R, Patel S, Rick C, Gray R, Clark CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653
11. Szentkiralyi A, Fendrich K, Hoffman W, Happe S, Berger K (2011) Incidence of restless legs syndrome in two population-based cohort studies in Germany. Sleep Med 12:815–820
12. Kagimura T, Nomura T, Kusumi M, Nakashima K, Inoue Y (2011) Prospective survey of the natural course of restless legs syndrome over two years in a closed cohort. Sleep Med 12:821–826
13. Lee J-E, Shin HW, Kim KS, Sohn YH (2009) Factors contributing to the development of restless legs syndrome in patients with Parkinson’s disease. Mov Disord 24:579–582
14. Shin H-Y, Youn J, Yoon WT, Kim JS, Cho JW (2013) Restless legs syndrome in Korean patients with drug-naïve Parkinson’s disease: A nation-wide study. Parkinsonism Relat Disord 19:355–358
15. Azmin S, Khairul Anuar AM, Nafisah WY, Tan HJ, Rajmond AA, Hanita O, Shah SA, Norlinah MI (2013) Restless Legs Syndrome and Its Associated Risk Factors in Parkinson’s Disease. Park Dis 535613
16. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M (2009) Defining Comorbidity: Implications for Understanding Health and Health Services. Ann Fam Med 7(4):357–363
17. Garcia-Borreguero D, Williams AM (2010) Dopaminergic augmentation of restless legs syndrome. Sleep Med 14:339–346